By: Melinda Telli, MD, Date: 12/9/2023 At the SABCS 2023 conference, we had the privilege…

By. Robert Rifkin, MDDate: 12/13/2023 Robert Rifkin, MD, a medical oncologist and hematologist at SCRI…

In an interview, Andrew Evens, DO, an expert in hematology and oncology, will discuss a…

In a discussion on cancer science, Wassim Mchayleh, MD, explores the role of Minimal Residual…

Allen Wilbanks stands at the forefront of SABCS 2023, the setting for a conversation with…

Zandra Klippel, MD, Global Product Head, Sanofi – Phase 3 IsKia trial of Sarclisa® (isatuximab)…

Under the lights of ASH 2023, the microphone poised to capture insights, Dr. Lorenzo Falchi,…

By. Saranya Chumsri, MD Date: 12/12/2023 Saranya Chumsri, MD, an expert in the field of…

At ASH 2023, Hamza Hashmi, MD, a medical doctor and hematologist from Charleston, South Carolina,…

By: Carol Fabian, MD Date. 12/07/2023 In an interview, Carol Fabian, MD, an expert in breast…